“…However, MBL concentrations are higher in patients with diabetes than in healthy subjects, despite similar MBL2 genotype distribution (2,6,12,13). Animal studies suggest this to be explained by a secondary increase in MBL concentration after diabetes induction (14). Finally, we recently showed that H-ficolin, another complement-activating pattern-recognition molecule, is also associated with development of diabetic kidney changes (15).…”